CAS No.37517-28-5,AMIKACIN Suppliers,MSDS download

Products Categories

Pharmaceutical (140)
Organic Chemicals (24)
Others (24)
Reagent (5)
Materials (4)
Basic Inorganic Chemicals (2)

Basic Information

Molecular Structure:
CAS No.:	37517-28-5
Name:	AMIKACIN
Article Data:	12

Formula:	C₂₂H₄₃N₅O₁₃
Molecular Weight:	585.609
Synonyms:	1-N-[L-(-)-g-Amino-a-hydroxybutyryl]kanamycin A;Amukin;Antibiotic BB-K 8;Arikace;BB-K 8;Lukadin;Potentox;
EINECS:	253-538-5
Density:	1.6 g/cm³
Melting Point:	203-204oC (sesquihydrate)
Boiling Point:	981.8 °C at 760 mmHg
Flash Point:	547.6 °C
Solubility:	water: 50 mg/mL, clear, colorless
Hazard Symbols:	Xi
Risk Codes:	36/37/38
Safety:	26-36
PSA:	331.94000
LogP:	-5.23210

Synthetic route

: C67H133N5O15Si10

: 37517-28-5
amikacin

Conditions

Conditions	Yield
With hydrogen bromide In water pH=2 - 3;	99.5%

: C30H45N5O15

: 37517-28-5
amikacin

Conditions

Conditions	Yield
With hydrazine hydrate for 4h; Reflux;	99%
With hydrazine hydrate In water at 20℃; for 3h; Reflux;	71.3%
With ammonium hydroxide

: 40732-91-0
γ-phthalimidoimino-α-hydroxybutyric acid

silyl kanamycin A: silyl kanamycin A

: 37517-28-5
amikacin

Conditions

Conditions	Yield
Stage #1: γ-phthalimidoimino-α-hydroxybutyric acid With 2-Mercaptobenzothiazole; triethylamine In dichloromethane at 20℃; for 3h; Stage #2: silyl kanamycin A In dichloromethane at 0 - 5℃; for 5h; Further stages;	93.6%

: C16H20N2O4S2

: 59-01-8
kanamycin A

: 37517-28-5
amikacin

Conditions

Conditions	Yield
Stage #1: kanamycin A With chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane In acetonitrile Reflux; Stage #2: C16H20N2O4S2 In acetone; acetonitrile at 0 - 5℃; for 1h; Stage #3: With hydrogenchloride In water; acetone; acetonitrile for 1h; pH=2 - 3; Solvent; Reagent/catalyst; Temperature;	83%

: C23H43N5O14

: 37517-28-5
amikacin

Conditions

Conditions	Yield
Stage #1: C23H43N5O14 With sodium hydroxide at -16 - 15℃; for 0.25h; Green chemistry; Stage #2: With sodium hypochlorite In water at -16 - -10℃; for 2h; Temperature; Hofmann Rearrangement; Green chemistry;	65.2%

: 39831-55-5
amikacin sulfate

: 37517-28-5
amikacin

Conditions

Conditions	Yield
With Amberlite ion exchange resin (OH-form) In water for 1h;

: C51H124N4O11Si11

: 37517-28-5
amikacin

Conditions

Conditions	Yield
Multi-step reaction with 3 steps 1.1: acetone / 0.5 h 1.2: 0.5 h / 0 °C 2.1: hydrogenchloride / water / 1 h / pH 2.34 3.1: hydrazine hydrate / water / 3 h / 20 °C / Reflux View Scheme

: C54H109N5O15Si8

: 37517-28-5
amikacin

Conditions

Conditions	Yield
Stage #1: C54H109N5O15Si8 With hydrogenchloride In water for 1h; pH=3; Stage #2: With hydrazine hydrate for 3h; Reflux;

: C22H41BrN4O13

: 37517-28-5
amikacin

Conditions

Conditions	Yield
With ammonia; potassium carbonate In acetone at 30℃; Temperature;

: 24424-99-5
di-tert-butyl dicarbonate

: 37517-28-5
amikacin

: tetra-N-Boc-amikacin

Conditions

Conditions	Yield
With triethylamine In 1,4-dioxane; dichloromethane; water at 20℃;	99%

Raw Materials

39831-55-5

Total:149 Page 1 of 4 1 2 3 4 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 37517-28-5

Chemistry

Product Name: Amikacin (CAS NO.37517-28-5)

Molecular Formula: C₂₂H₄₃N₅O₁₃
Molecular Weight: 585.6g/mol
Mol File: 37517-28-5.mol
Einecs: 253-538-5
Boiling point: 981.8 °C at 760 mmHg
Storage Temperature: 2-8°C
Flash Point: 547.6 °C
Density: 1.6 g/cm³
Water Solubility: 50 mg/mL, clear, colorless
Surface Tension: 103.2 dyne/cm
Enthalpy of Vaporization: 162.21 kJ/mol
Structure Descriptors of Amikacin (CAS NO.37517-28-5):
InChI : InChI=1/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1
Smiles: O([C@H]1[C@@H](C[C@H](N)[C@H]([C@@H]1O)O[C@H]1O[C@@H]([C@@H](O)[C@@H]([C@H]1O)O)CN)NC([C@H](CCN)O)=O)[C@H]1O[C@@H]([C@@H](O)[C@@H]([C@H]1O)N)CO

Uses

Amikacin (CAS NO.37517-28-5) is most often used for treating severe, hospital-acquired infections with multidrug resistant Gram negative bacteria such as Pseudomonas aeruginosa, Acinetobacter, and Enterobacter.
Amikacin may be combined with a beta-lactam antibiotic for empiric therapy for people with neutropenia and fever.

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intramuscular	6200mg/kg (6200mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
mouse	LD50	intraperitoneal	750mg/kg (750mg/kg)	PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)	Antimicrobial Agents and Chemotherapy. Vol. 13, Pg. 41, 1978.
mouse	LD50	intravenous	280mg/kg (280mg/kg)		Journal of Antibiotics. Vol. 43, Pg. 858, 1990.
mouse	LD50	oral	> 6gm/kg (6000mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
mouse	LD50	subcutaneous	6200mg/kg (6200mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.

Safety Profile

Safety Information of Amikacin (CAS NO.37517-28-5):
Hazard Codes: Xi Irritant
Risk Statements: 36/37/38
36: Irritating to the eyes
37: Irritating to the respiratory system
38: Irritating to the skin
Safety Statements: 26-36
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36: Wear suitable protective clothing

Specification

Amikacin ,its CAS NO. is 37517-28-5,the synonyms is 1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A ; Amiglyde-V ; Amikacin Inhalation Solution ; Amikacinum ; Amikavet ; Antibiotic BB-K 8 ; BAY41-6551 ; BB-K 8 ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)- ; EINECS 253-538-5 ; HSDB 3583 ; Kaminax ; Lukadin ; Mikavir ; NSC 177001 ; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-
deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine ; Pierami ; UNII-84319SGC3C ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)- ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)- ; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-N1-((2S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy- .